Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada
Press Releases
Endo, Inc.  
November 15, 2024

Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora® Cream in Canada

MALVERN, Pa., Nov. 15, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today that it has entered into a definitive agreement with MC2 Therapeutics ("MC2") to commercialize Wynzora® Cream (calcipotriene

avatar profile Olean Times Herald

Olean Times Herald


Local & Social